Align Technology | ALGN - Cash And Equivalent


Align Technology reported $1.1B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
3M USD 2.96B 774M Jun/2026
Align Technology USD 1.1B 42.76M Jun/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Cooper Companies USD 124.9M 14.3M Dec/2025
CVS Health USD 11.33B 1.79B Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Dentsply International USD 239M 49M Jun/2026
Dexcom USD 1.1B 13.2M Jun/2026
Henry Schein USD 138M 18M Mar/2026
Idexx Laboratories USD 196.93M 3.6M Jun/2026
Insulet USD 534.9M 54.5M Jun/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
McKesson USD 5.16B 1.19B Jun/2026
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
Solventum Corp USD 403M 158M Jun/2026
Stryker USD 3.39B 513M Jun/2026
Teleflex USD 300.16M 9.25M Jun/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Veeva Systems USD 1.9B 475.35M Mar/2026
Waters USD 539M 77M Jun/2026
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026
Zoetis USD 1.48B 465M Jun/2026